0
0
9/16/22 at 4:08pm
Organization
Healthday.com
Author
Physician’s Briefing Staff
28 words
0
Comments
Overall risk-benefit ratio seems to favor patients receiving linezolid at dose of 600 mg for 26 weeks
You are the first to view
https://consumer.healthday.com/bedaquiline-pretomanid-linezolid-regimens-compared-for-xdr-tb-2657965270.html
Create an account
or login to join the discussion